March 13, 2019
HemoSonics has announced that its innovative Quantra Hemostasis Analyzer platform, and its initial QPlus cartridge have been granted de novo marketing authorization by the FDA and are now available for sale in the United States. Read More
September 18, 2018
Many thanks to the attendees, speakers and organizers at the Society for the Advancement of Blood Management, Inc. (SABM) 2018 annual meeting in Brooklyn from 12-15 Sept. It was a top notch showing and an excellent educational experience for all of us! Read More
May 24, 2018
HemoSonics will be participating in the scientific proceedings as well as have a commercial presence at Euroanesthesia (ESA), to be held in Copenhagen, Denmark on June 2-4th. Read More
October 19, 2017
HemoSonics has announced the appointment of Remi Corlin, a 20-year medical device and diagnostic industry veteran, as VP International Markets to lead the rollout of the Quantra Hemostasis Analyzer in markets outside of the US. Read More
July 11, 2017
HemoSonics has announced the presentation of scientific and clinical data at the XXVI International Society on Thrombosis and Hemostasis (ISTH) Congress in Berlin, Germany. Read More
May 30, 2017
The Stago group announced today that it has completed the acquisition of HemoSonics LLC, a company specialized in the development of innovative Point-of-Care testing solutions based in Charlottesville, VA, with facilities in Durham, NC (USA). Read More
